Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Single Site Robotic Cholecystectomy in Non Selected Patients
Single Site Robotic Cholecystectomy in Non Selected Patients
Status: Enrolling
Updated:  9/22/2017
UC Davis Medical Center
mi
from
Sacramento, CA
Single Site Robotic Cholecystectomy in Non Selected Patients
Single Site Robotic Cholecystectomy in Non Selected Patients
Status: Enrolling
Updated: 9/22/2017
UC Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Phase 1, Open-Label Study of Intravenous Sildenafil in Patients With Cirrhosis
A Phase 1, Open-Label Study of Intravenous Sildenafil in Patients With Cirrhosis
Status: Enrolling
Updated:  9/25/2017
University of Maryland, Baltimore
mi
from
Baltimore, MD
A Phase 1, Open-Label Study of Intravenous Sildenafil in Patients With Cirrhosis
A Phase 1, Open-Label Study of Intravenous Sildenafil in Patients With Cirrhosis
Status: Enrolling
Updated: 9/25/2017
University of Maryland, Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Intranasal Recombinant Flagellin Subunit Campylobacter Vaccine (rFla-MBP) Dose-Ranging Study
Safety and Immunogenicity Evaluation of an Intranasal Recombinant Flagellin Subunit Campylobacter Vaccine (rFla-MBP) in Volunteers
Status: Enrolling
Updated:  9/25/2017
Walter Reed Army Institute for Research
mi
from
Silver Spring, MD
Intranasal Recombinant Flagellin Subunit Campylobacter Vaccine (rFla-MBP) Dose-Ranging Study
Safety and Immunogenicity Evaluation of an Intranasal Recombinant Flagellin Subunit Campylobacter Vaccine (rFla-MBP) in Volunteers
Status: Enrolling
Updated: 9/25/2017
Walter Reed Army Institute for Research
mi
from
Silver Spring, MD
Click here to add this to my saved trials
Curcumin in Treating Patients With Familial Adenomatous Polyposis
Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)
Status: Enrolling
Updated:  9/27/2017
Johns Hopkins University-Sidney Kimmel Cancer Center
mi
from
Baltimore, MD
Curcumin in Treating Patients With Familial Adenomatous Polyposis
Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)
Status: Enrolling
Updated: 9/27/2017
Johns Hopkins University-Sidney Kimmel Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Curcumin in Treating Patients With Familial Adenomatous Polyposis
Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)
Status: Enrolling
Updated:  9/27/2017
Univ of Puerto Rico
mi
from
San Juan,
Curcumin in Treating Patients With Familial Adenomatous Polyposis
Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)
Status: Enrolling
Updated: 9/27/2017
Univ of Puerto Rico
mi
from
San Juan,
Click here to add this to my saved trials
Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes With Refractory Corneal Infection
Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes With Refractory Corneal Infection
Status: Enrolling
Updated:  9/27/2017
Harkness Eye Institute/ Columbia University
mi
from
New York, NY
Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes With Refractory Corneal Infection
Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes With Refractory Corneal Infection
Status: Enrolling
Updated: 9/27/2017
Harkness Eye Institute/ Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy
Comparison of FibroScan With Histological Evaluations of Liver Fibrosis in Patients With Hepatitis B and C Presenting for Liver Biopsy
Status: Enrolling
Updated:  9/28/2017
BIDMC
mi
from
Boston, MA
FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy
Comparison of FibroScan With Histological Evaluations of Liver Fibrosis in Patients With Hepatitis B and C Presenting for Liver Biopsy
Status: Enrolling
Updated: 9/28/2017
BIDMC
mi
from
Boston, MA
Click here to add this to my saved trials
FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy
Comparison of FibroScan With Histological Evaluations of Liver Fibrosis in Patients With Hepatitis B and C Presenting for Liver Biopsy
Status: Enrolling
Updated:  9/28/2017
Duke Univ Med Ctr
mi
from
Durham, NC
FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy
Comparison of FibroScan With Histological Evaluations of Liver Fibrosis in Patients With Hepatitis B and C Presenting for Liver Biopsy
Status: Enrolling
Updated: 9/28/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy
Comparison of FibroScan With Histological Evaluations of Liver Fibrosis in Patients With Hepatitis B and C Presenting for Liver Biopsy
Status: Enrolling
Updated:  9/28/2017
Bruce Bacon M.D.
mi
from
Saint Louis, MO
FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy
Comparison of FibroScan With Histological Evaluations of Liver Fibrosis in Patients With Hepatitis B and C Presenting for Liver Biopsy
Status: Enrolling
Updated: 9/28/2017
Bruce Bacon M.D.
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine Versus Rectal Indomethacin to Prevent Post-ERCP Pancreatitis
A Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine Versus Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in High Risk Patients
Status: Enrolling
Updated:  10/2/2017
Johns Hopkins Medical Institutions
mi
from
Baltimore, MD
Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine Versus Rectal Indomethacin to Prevent Post-ERCP Pancreatitis
A Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine Versus Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in High Risk Patients
Status: Enrolling
Updated: 10/2/2017
Johns Hopkins Medical Institutions
mi
from
Baltimore, MD
Click here to add this to my saved trials
Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine Versus Rectal Indomethacin to Prevent Post-ERCP Pancreatitis
A Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine Versus Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in High Risk Patients
Status: Enrolling
Updated:  10/2/2017
Asian Institute of gastroenterology
mi
from
Hyderabad,
Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine Versus Rectal Indomethacin to Prevent Post-ERCP Pancreatitis
A Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine Versus Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in High Risk Patients
Status: Enrolling
Updated: 10/2/2017
Asian Institute of gastroenterology
mi
from
Hyderabad,
Click here to add this to my saved trials
Miromatrix Biological Mesh for Ventral Hernia Repair
A Prospective Post-Market Clinical Evaluation of Miromatrix Biological Mesh for Ventral Hernia Repair
Status: Enrolling
Updated:  10/2/2017
Sarasota Memorial Hospital
mi
from
Sarasota, FL
Miromatrix Biological Mesh for Ventral Hernia Repair
A Prospective Post-Market Clinical Evaluation of Miromatrix Biological Mesh for Ventral Hernia Repair
Status: Enrolling
Updated: 10/2/2017
Sarasota Memorial Hospital
mi
from
Sarasota, FL
Click here to add this to my saved trials
Miromatrix Biological Mesh for Ventral Hernia Repair
A Prospective Post-Market Clinical Evaluation of Miromatrix Biological Mesh for Ventral Hernia Repair
Status: Enrolling
Updated:  10/2/2017
University of Kentucky
mi
from
Lexington, KY
Miromatrix Biological Mesh for Ventral Hernia Repair
A Prospective Post-Market Clinical Evaluation of Miromatrix Biological Mesh for Ventral Hernia Repair
Status: Enrolling
Updated: 10/2/2017
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Miromatrix Biological Mesh for Ventral Hernia Repair
A Prospective Post-Market Clinical Evaluation of Miromatrix Biological Mesh for Ventral Hernia Repair
Status: Enrolling
Updated:  10/2/2017
University of Wisconsin
mi
from
Madison, WI
Miromatrix Biological Mesh for Ventral Hernia Repair
A Prospective Post-Market Clinical Evaluation of Miromatrix Biological Mesh for Ventral Hernia Repair
Status: Enrolling
Updated: 10/2/2017
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Miromatrix Biological Mesh for Ventral Hernia Repair
A Prospective Post-Market Clinical Evaluation of Miromatrix Biological Mesh for Ventral Hernia Repair
Status: Enrolling
Updated:  10/2/2017
Penn State Hershey Medical Center
mi
from
Hershey, PA
Miromatrix Biological Mesh for Ventral Hernia Repair
A Prospective Post-Market Clinical Evaluation of Miromatrix Biological Mesh for Ventral Hernia Repair
Status: Enrolling
Updated: 10/2/2017
Penn State Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Status: Enrolling
Updated:  10/2/2017
North Little Rock
mi
from
North Little Rock, AR
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Status: Enrolling
Updated: 10/2/2017
North Little Rock
mi
from
North Little Rock, AR
Click here to add this to my saved trials
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Status: Enrolling
Updated:  10/2/2017
Manhattan
mi
from
New York, NY
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Status: Enrolling
Updated: 10/2/2017
Manhattan
mi
from
New York, NY
Click here to add this to my saved trials
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Status: Enrolling
Updated:  10/2/2017
Manhattan
mi
from
New York, NY
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Status: Enrolling
Updated: 10/2/2017
Manhattan
mi
from
New York, NY
Click here to add this to my saved trials
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Status: Enrolling
Updated:  10/2/2017
Manhattan
mi
from
New York, NY
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Status: Enrolling
Updated: 10/2/2017
Manhattan
mi
from
New York, NY
Click here to add this to my saved trials
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Status: Enrolling
Updated:  10/2/2017
Investigator Site - Cincinnati
mi
from
Cincinnati, OH
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Status: Enrolling
Updated: 10/2/2017
Investigator Site - Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Status: Enrolling
Updated:  10/2/2017
Hagerstown
mi
from
Hagerstown, MD
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Status: Enrolling
Updated: 10/2/2017
Hagerstown
mi
from
Hagerstown, MD
Click here to add this to my saved trials
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Status: Enrolling
Updated:  10/2/2017
Hollywood
mi
from
Hollywood, FL
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Status: Enrolling
Updated: 10/2/2017
Hollywood
mi
from
Hollywood, FL
Click here to add this to my saved trials
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Status: Enrolling
Updated:  10/2/2017
Winter Park
mi
from
Winter Park, FL
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Status: Enrolling
Updated: 10/2/2017
Winter Park
mi
from
Winter Park, FL
Click here to add this to my saved trials
Bowel Preparation for Inpatient Colonoscopy
Single Blind, Randomized, Controlled Trial of Conventional Versus Split-Dose Bowel Preparation for Inpatient Colonoscopy
Status: Enrolling
Updated:  10/3/2017
Santa Clara Valley Medical Center
mi
from
San Jose, CA
Bowel Preparation for Inpatient Colonoscopy
Single Blind, Randomized, Controlled Trial of Conventional Versus Split-Dose Bowel Preparation for Inpatient Colonoscopy
Status: Enrolling
Updated: 10/3/2017
Santa Clara Valley Medical Center
mi
from
San Jose, CA
Click here to add this to my saved trials
Study of the Efficiency of Esophageal Dilation on Patient With Eosinophilic Esophagitis
Prospective, Single-Blinded, Randomized Controlled Trial With Sham Comparing Standard Therapy With or Without Esophageal Dilatation in Patients With Eosinophilic Esophagitis
Status: Enrolling
Updated:  10/4/2017
Vanderbilt Unversity Medical Center Department of Gastroenterology
mi
from
Nashville, TN
Study of the Efficiency of Esophageal Dilation on Patient With Eosinophilic Esophagitis
Prospective, Single-Blinded, Randomized Controlled Trial With Sham Comparing Standard Therapy With or Without Esophageal Dilatation in Patients With Eosinophilic Esophagitis
Status: Enrolling
Updated: 10/4/2017
Vanderbilt Unversity Medical Center Department of Gastroenterology
mi
from
Nashville, TN
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
An Evaluation of the Pharmacokinetic Profile and Safety of a Single Dose of Daptomycin in Pediatric Subjects Aged 3 Months to Twenty-Four Months Who Are Concurrently Receiving Standard Antibiotic Therapy for Proven or Suspected Bacterial Infection Including Peri-Operative Prophylactic Use of Antibiotics
Status: Enrolling
Updated:  10/4/2017
Arkansas Children's Hospital
mi
from
Little Rock, AR
Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
An Evaluation of the Pharmacokinetic Profile and Safety of a Single Dose of Daptomycin in Pediatric Subjects Aged 3 Months to Twenty-Four Months Who Are Concurrently Receiving Standard Antibiotic Therapy for Proven or Suspected Bacterial Infection Including Peri-Operative Prophylactic Use of Antibiotics
Status: Enrolling
Updated: 10/4/2017
Arkansas Children's Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
An Evaluation of the Pharmacokinetic Profile and Safety of a Single Dose of Daptomycin in Pediatric Subjects Aged 3 Months to Twenty-Four Months Who Are Concurrently Receiving Standard Antibiotic Therapy for Proven or Suspected Bacterial Infection Including Peri-Operative Prophylactic Use of Antibiotics
Status: Enrolling
Updated:  10/4/2017
University of Louisiana at Monroe
mi
from
Shreveport, LA
Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
An Evaluation of the Pharmacokinetic Profile and Safety of a Single Dose of Daptomycin in Pediatric Subjects Aged 3 Months to Twenty-Four Months Who Are Concurrently Receiving Standard Antibiotic Therapy for Proven or Suspected Bacterial Infection Including Peri-Operative Prophylactic Use of Antibiotics
Status: Enrolling
Updated: 10/4/2017
University of Louisiana at Monroe
mi
from
Shreveport, LA
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
An Evaluation of the Pharmacokinetic Profile and Safety of a Single Dose of Daptomycin in Pediatric Subjects Aged 3 Months to Twenty-Four Months Who Are Concurrently Receiving Standard Antibiotic Therapy for Proven or Suspected Bacterial Infection Including Peri-Operative Prophylactic Use of Antibiotics
Status: Enrolling
Updated:  10/4/2017
Toledo Children's Hospital
mi
from
Toledo, OH
Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
An Evaluation of the Pharmacokinetic Profile and Safety of a Single Dose of Daptomycin in Pediatric Subjects Aged 3 Months to Twenty-Four Months Who Are Concurrently Receiving Standard Antibiotic Therapy for Proven or Suspected Bacterial Infection Including Peri-Operative Prophylactic Use of Antibiotics
Status: Enrolling
Updated: 10/4/2017
Toledo Children's Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
An Evaluation of the Pharmacokinetic Profile and Safety of a Single Dose of Daptomycin in Pediatric Subjects Aged 3 Months to Twenty-Four Months Who Are Concurrently Receiving Standard Antibiotic Therapy for Proven or Suspected Bacterial Infection Including Peri-Operative Prophylactic Use of Antibiotics
Status: Enrolling
Updated:  10/4/2017
Children's Hospital of Orange County
mi
from
Orange, CA
Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
An Evaluation of the Pharmacokinetic Profile and Safety of a Single Dose of Daptomycin in Pediatric Subjects Aged 3 Months to Twenty-Four Months Who Are Concurrently Receiving Standard Antibiotic Therapy for Proven or Suspected Bacterial Infection Including Peri-Operative Prophylactic Use of Antibiotics
Status: Enrolling
Updated: 10/4/2017
Children's Hospital of Orange County
mi
from
Orange, CA
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
An Evaluation of the Pharmacokinetic Profile and Safety of a Single Dose of Daptomycin in Pediatric Subjects Aged 3 Months to Twenty-Four Months Who Are Concurrently Receiving Standard Antibiotic Therapy for Proven or Suspected Bacterial Infection Including Peri-Operative Prophylactic Use of Antibiotics
Status: Enrolling
Updated:  10/4/2017
Rady Children's Hospital - San Diego
mi
from
San Diego, CA
Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
An Evaluation of the Pharmacokinetic Profile and Safety of a Single Dose of Daptomycin in Pediatric Subjects Aged 3 Months to Twenty-Four Months Who Are Concurrently Receiving Standard Antibiotic Therapy for Proven or Suspected Bacterial Infection Including Peri-Operative Prophylactic Use of Antibiotics
Status: Enrolling
Updated: 10/4/2017
Rady Children's Hospital - San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
An Evaluation of the Pharmacokinetic Profile and Safety of a Single Dose of Daptomycin in Pediatric Subjects Aged 3 Months to Twenty-Four Months Who Are Concurrently Receiving Standard Antibiotic Therapy for Proven or Suspected Bacterial Infection Including Peri-Operative Prophylactic Use of Antibiotics
Status: Enrolling
Updated:  10/4/2017
Children's Mercy Hospital and Clinics
mi
from
Kansas City, MO
Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
An Evaluation of the Pharmacokinetic Profile and Safety of a Single Dose of Daptomycin in Pediatric Subjects Aged 3 Months to Twenty-Four Months Who Are Concurrently Receiving Standard Antibiotic Therapy for Proven or Suspected Bacterial Infection Including Peri-Operative Prophylactic Use of Antibiotics
Status: Enrolling
Updated: 10/4/2017
Children's Mercy Hospital and Clinics
mi
from
Kansas City, MO
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
An Evaluation of the Pharmacokinetic Profile and Safety of a Single Dose of Daptomycin in Pediatric Subjects Aged 3 Months to Twenty-Four Months Who Are Concurrently Receiving Standard Antibiotic Therapy for Proven or Suspected Bacterial Infection Including Peri-Operative Prophylactic Use of Antibiotics
Status: Enrolling
Updated:  10/4/2017
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
An Evaluation of the Pharmacokinetic Profile and Safety of a Single Dose of Daptomycin in Pediatric Subjects Aged 3 Months to Twenty-Four Months Who Are Concurrently Receiving Standard Antibiotic Therapy for Proven or Suspected Bacterial Infection Including Peri-Operative Prophylactic Use of Antibiotics
Status: Enrolling
Updated: 10/4/2017
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
An Evaluation of the Pharmacokinetic Profile and Safety of a Single Dose of Daptomycin in Pediatric Subjects Aged 3 Months to Twenty-Four Months Who Are Concurrently Receiving Standard Antibiotic Therapy for Proven or Suspected Bacterial Infection Including Peri-Operative Prophylactic Use of Antibiotics
Status: Enrolling
Updated:  10/4/2017
Cook Children's Medical Center
mi
from
Fort Worth, TX
Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
An Evaluation of the Pharmacokinetic Profile and Safety of a Single Dose of Daptomycin in Pediatric Subjects Aged 3 Months to Twenty-Four Months Who Are Concurrently Receiving Standard Antibiotic Therapy for Proven or Suspected Bacterial Infection Including Peri-Operative Prophylactic Use of Antibiotics
Status: Enrolling
Updated: 10/4/2017
Cook Children's Medical Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of Daclatasvir/Sofosbuvir/Ribavirin for 16 Versus 24 Weeks for HCV Genotype 3 Cirrhotics
A Randomized Study to Evaluate the Safety and Efficacy of Adding Daclatasvir to the Combination of Sofosbuvir (SOF) and Ribavirin (RBV) for 16 Weeks Versus 24 Weeks in Cirrhotic Subjects With Chronic Hepatitis C Infection Genotype 3
Status: Enrolling
Updated:  10/4/2017
Southern California Research Center
mi
from
Coronado, CA
Study to Evaluate the Safety and Efficacy of Daclatasvir/Sofosbuvir/Ribavirin for 16 Versus 24 Weeks for HCV Genotype 3 Cirrhotics
A Randomized Study to Evaluate the Safety and Efficacy of Adding Daclatasvir to the Combination of Sofosbuvir (SOF) and Ribavirin (RBV) for 16 Weeks Versus 24 Weeks in Cirrhotic Subjects With Chronic Hepatitis C Infection Genotype 3
Status: Enrolling
Updated: 10/4/2017
Southern California Research Center
mi
from
Coronado, CA
Click here to add this to my saved trials
Imuran Dosing in Crohn's Disease Study
A Multi-site Trial of Azathioprine Dosing in Crohn's Disease
Status: Enrolling
Updated:  10/4/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Imuran Dosing in Crohn's Disease Study
A Multi-site Trial of Azathioprine Dosing in Crohn's Disease
Status: Enrolling
Updated: 10/4/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Imuran Dosing in Crohn's Disease Study
A Multi-site Trial of Azathioprine Dosing in Crohn's Disease
Status: Enrolling
Updated:  10/4/2017
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
Imuran Dosing in Crohn's Disease Study
A Multi-site Trial of Azathioprine Dosing in Crohn's Disease
Status: Enrolling
Updated: 10/4/2017
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
Click here to add this to my saved trials
Imuran Dosing in Crohn's Disease Study
A Multi-site Trial of Azathioprine Dosing in Crohn's Disease
Status: Enrolling
Updated:  10/4/2017
University of Chicago Pediatric Gastroenterology
mi
from
Chicago, IL
Imuran Dosing in Crohn's Disease Study
A Multi-site Trial of Azathioprine Dosing in Crohn's Disease
Status: Enrolling
Updated: 10/4/2017
University of Chicago Pediatric Gastroenterology
mi
from
Chicago, IL
Click here to add this to my saved trials
Imuran Dosing in Crohn's Disease Study
A Multi-site Trial of Azathioprine Dosing in Crohn's Disease
Status: Enrolling
Updated:  10/4/2017
University of Chicago
mi
from
Chicago, IL
Imuran Dosing in Crohn's Disease Study
A Multi-site Trial of Azathioprine Dosing in Crohn's Disease
Status: Enrolling
Updated: 10/4/2017
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Imuran Dosing in Crohn's Disease Study
A Multi-site Trial of Azathioprine Dosing in Crohn's Disease
Status: Enrolling
Updated:  10/4/2017
Johns Hopkins University
mi
from
Baltimore, MD
Imuran Dosing in Crohn's Disease Study
A Multi-site Trial of Azathioprine Dosing in Crohn's Disease
Status: Enrolling
Updated: 10/4/2017
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Imuran Dosing in Crohn's Disease Study
A Multi-site Trial of Azathioprine Dosing in Crohn's Disease
Status: Enrolling
Updated:  10/4/2017
Duluth Clinic
mi
from
Duluth, MN
Imuran Dosing in Crohn's Disease Study
A Multi-site Trial of Azathioprine Dosing in Crohn's Disease
Status: Enrolling
Updated: 10/4/2017
Duluth Clinic
mi
from
Duluth, MN
Click here to add this to my saved trials
Imuran Dosing in Crohn's Disease Study
A Multi-site Trial of Azathioprine Dosing in Crohn's Disease
Status: Enrolling
Updated:  10/4/2017
The Mayo Clinic
mi
from
Rochester, MN
Imuran Dosing in Crohn's Disease Study
A Multi-site Trial of Azathioprine Dosing in Crohn's Disease
Status: Enrolling
Updated: 10/4/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Imuran Dosing in Crohn's Disease Study
A Multi-site Trial of Azathioprine Dosing in Crohn's Disease
Status: Enrolling
Updated:  10/4/2017
Long Island Clinical Research Assoc.
mi
from
Great Neck, NY
Imuran Dosing in Crohn's Disease Study
A Multi-site Trial of Azathioprine Dosing in Crohn's Disease
Status: Enrolling
Updated: 10/4/2017
Long Island Clinical Research Assoc.
mi
from
Great Neck, NY
Click here to add this to my saved trials
Imuran Dosing in Crohn's Disease Study
A Multi-site Trial of Azathioprine Dosing in Crohn's Disease
Status: Enrolling
Updated:  10/4/2017
Mt. Sinai Medical Center
mi
from
New York, NY
Imuran Dosing in Crohn's Disease Study
A Multi-site Trial of Azathioprine Dosing in Crohn's Disease
Status: Enrolling
Updated: 10/4/2017
Mt. Sinai Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Imuran Dosing in Crohn's Disease Study
A Multi-site Trial of Azathioprine Dosing in Crohn's Disease
Status: Enrolling
Updated:  10/4/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Imuran Dosing in Crohn's Disease Study
A Multi-site Trial of Azathioprine Dosing in Crohn's Disease
Status: Enrolling
Updated: 10/4/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Imuran Dosing in Crohn's Disease Study
A Multi-site Trial of Azathioprine Dosing in Crohn's Disease
Status: Enrolling
Updated:  10/4/2017
Cincinnati Children's Hospital
mi
from
Cincinnati, OH
Imuran Dosing in Crohn's Disease Study
A Multi-site Trial of Azathioprine Dosing in Crohn's Disease
Status: Enrolling
Updated: 10/4/2017
Cincinnati Children's Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Imuran Dosing in Crohn's Disease Study
A Multi-site Trial of Azathioprine Dosing in Crohn's Disease
Status: Enrolling
Updated:  10/4/2017
University of Pittsburgh
mi
from
Pittsburgh, PA
Imuran Dosing in Crohn's Disease Study
A Multi-site Trial of Azathioprine Dosing in Crohn's Disease
Status: Enrolling
Updated: 10/4/2017
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Imuran Dosing in Crohn's Disease Study
A Multi-site Trial of Azathioprine Dosing in Crohn's Disease
Status: Enrolling
Updated:  10/4/2017
University of Alberta
mi
from
Edmonton,
Imuran Dosing in Crohn's Disease Study
A Multi-site Trial of Azathioprine Dosing in Crohn's Disease
Status: Enrolling
Updated: 10/4/2017
University of Alberta
mi
from
Edmonton,
Click here to add this to my saved trials
Minimally Invasive Closure of Umbilical Hernias
Study of Minimally Invasive Closure of Umbilical Hernias
Status: Enrolling
Updated:  10/4/2017
Children's Hospital Boston and South Shore Hospital
mi
from
South Weymouth, MA
Minimally Invasive Closure of Umbilical Hernias
Study of Minimally Invasive Closure of Umbilical Hernias
Status: Enrolling
Updated: 10/4/2017
Children's Hospital Boston and South Shore Hospital
mi
from
South Weymouth, MA
Click here to add this to my saved trials
Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal Disorders
Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal Disorders
Status: Enrolling
Updated:  10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal Disorders
Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal Disorders
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal Cancers
A Pilot Study of Markers of Tumor Burden and Radiation Toxicity in the Blood, Urine, and Stool of Patients Receiving Radiotherapy for Gastrointestinal Malignancies
Status: Enrolling
Updated:  10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal Cancers
A Pilot Study of Markers of Tumor Burden and Radiation Toxicity in the Blood, Urine, and Stool of Patients Receiving Radiotherapy for Gastrointestinal Malignancies
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials